Histamine-N-Methyl transferase polymorphism and risk for migraine: Research submission

Headache

Volumn 48, Issue 9, 2008, Pages 1343-1348

  García Martín, Elena ^a   Martínez, Carmen ^a   Serrador, Mercedes ^b   Alonso Navarro, Hortensia ^c   Navacerrada, Francisco ^d   Agúndez, José A G ^a   Jiménez Jiménez, Félix Javier ^b  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c HOSPITAL VIRGEN DE LA CONCHA   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Genetic polymorphisms; Genetics; Histamine n methyl transferase; Migraine; Risk factors

Indexed keywords

HISTAMINE METHYLTRANSFERASE;

ADULT; ALLELE; ALLERGIC DISEASE; ARTICLE; CONTROLLED STUDY; ENZYME POLYMORPHISM; FAMILY HISTORY; FEMALE; GENDER; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE AURA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK;

ADULT; AGE OF ONSET; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTAMINE N-METHYLTRANSFERASE; HUMANS; MALE; MIGRAINE DISORDERS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS;

EID: 53849099303     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.01056.x     Document Type: Article

References (27)

1. Rasmussen BK. Epidemiology of migraine. In : Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches. 3rd edn. Philadelphia : Lippincot Williams & Wilkins 2006 : 235 242.
2. Russell MD, Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ. 1995 311 : 541 544.
3. Ophoff RA, Terwint GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1Ar. Cell. 1996 87 : 543 552.
4. De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003 33 : 192 196.
5. Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005 366 : 371 377.
6. Weaber C. Serotonin and other biogenic amines. In : Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches. 3rd edn. Philadelphia : Lippincot Williams & Wilkins 2006 : 143 149.
7. Panula P, Yang HY, Costa E. Histamine-containing neurons in the rat hypothalamus. Proc Natl Acad Sci USA. 1984 81 : 2572 2576.
8. Watanabe T, Taguchi Y, Shiosaka S, Tanaka J, Kubota H, Terano Y, et al. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res. 1984 295 : 13 25.
9. Kim SH, Krapfenbauer K, Cheon MS, Fountoulakis M, Caims NJ, Lubec G. Human brain cytosolic histamine-N-methyltranferase is decreased in Down syndrome and increased in Pick's disease. Neurosci Lett. 2002 321 : 169 172.
10. Obata T. Semicarbazide-sensitive amine oxidase (SSAO) in the brain. Neurochem Res. 2002 27 : 263 268.
11. Preuss CV, Wood TC, Szumlanski CL, Raftogianis RB, Otterness DM, Girard B, et al. Human histamine N-methyltransferase pharmacogenetics: Common genetic polymorphism that alter activity. Mol Pharmacol. 1998 53 : 708 717.
12. Bulpitt CJ. Confidence intervals. Lancet. 1987 i : 494 497.
13. Ku M, Silverman B, Prifti N, Ying W, Persaud Y, Schneider A. Prevalence of migraine headaches in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2006 97 : 226 230.
14. Aamodt AH, Stovner LJ, Langhammer A, Hagen K, Zwart JA. Is headache related to asthma, hay fever, and chronic bronchitis? The Head-HUNT study. Headache. 2007 47 : 204 212.
15. Heatley RV, Denburg JA, Bayer N, Bienenstock J. Increased plasma histamine levels in migraine patients. Clin Allergy. 1982 12 : 145 149.
16. Haimart M, Pradalier A, Launay JM, Dreux C, Dry J. Whole blood and plasma histamine in common migraine. Cephalalgia. 1987 7 : 39 42.
17. Gazerani P, Pourpak Z, Ahmadiani A, Hemmati A, Kazemnejad A. A correlation between migraine, histamine and immunoglobulin E. Scand J Immunol. 2003 57 : 286 290.
18. Kemper RH, Meijler WJ, Korf J, Ter Horst GJ. Migraine and function of the immune system: A metaanalysis of clinical literature published between 1966 and 1999. Cephalalgia. 2001 21 : 549 557.
19. Castillo J, Martínez F, Corredera E, Lema M, Noya M. Migraña e histamine: Determinación de histidina en plasma y líquido cefalorraquídeo durante crisis de migraña. Rev Neurol. 1995 23 : 749 751.
20. Sanders WM, Zimmerman AW, Mahoney MA, Ballow M. Leucocyte histamine release in migraine. Headache. 1980 20 : 307 310.
21. Selmaj K. Histamine release from leucocytes in migraine. Cephalalgia. 1983 3 : 37 40.
22. Selmaj K. Histamine release from leucocytes during migraine attack. Cephalalgia. 1984 4 : 97 100.
23. Launay JM, Pradalier A, Haimart M, Artigou C, Dreux C, Dry J. Histaminoliberation et migraine. Rev Med Interne. 1987 8 : 273 275.
24. Reuter U, Bolay H, Jansen Olesen I, et al. Delayed inflammation in rat meninges: Implications for migraine pathophysiology. Brain. 2001 124 : 2490 2502.
25. Krabbe AA, Olesen J. Headache provocation by continous intravenous infusion of histamine. Clinical results and receptor mechanisms. Pain. 1980 8 : 253 259.
26. Lassen LH, Thomsen LL, Olesen J. Histamine induces migraine via the H1 receptor. Support for the NO hypothesis of migraine. Neuroreport. 1995 6 : 1475 1479.
27. Millán-Guerrero RO, Isais-Millán R, Benjamín TH, Tene CE. N-alpha-methyl histamine safety and efficacy in migraine prophylaxis: Phase III study. Can J Neurol Sci. 2006 33 : 195 199.